Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722305 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



Market Dynamics 2001: Diabetes
Datamonitor, Feb 2002


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

Few non-infectious diseases are growing as rapidly as type II diabetes. More than 37 million people in seven major pharmaceutical markets now have type II diabetes, and recent data reveal that the disease is on the rise in other markets as well. Daily news accounts about the rise in diabetes and the disease''s insidious, yet severe, complications will lead to higher diagnosis rates and demand for more effective treatments. The diabetes market is undergoing a major upheaval. Bristol-Myers Squibb''s Glucophage (metformin), the most widely prescribed therapy for type II diabetes, lost patent protection in the U.S. market in 2001. Further, novel formulations of insulin (e.g. Lantus from Aventis), advances in insulin delivery, and new insulin sensitizing drugs will all dramatically impact the market. This analysis provides essential insight into the diabetes market. Market Dynamics 2001: Diabetes - Face of the Diabetes Market analyzes the driving forces behind the current diabetes market, examining the factors that will sustain and impede growth in coming years. Specific issues discussed in the report include: • Current unmet clinical needs in the treatment of diabetes as viewed by physicians in the seven major pharmaceutical markets • Treatment trends in the major markets, including increased use of insulin to treat type II diabetes • Cost containment and price control measures affecting diabetes prescribing in the major markets • The success behind the current market leaders in each drug class across the seven major markets, including marketing strength and strategies, drug characteristics and geographical location


Customers who bought this item also bought

Drugs of Tomorrow 2001: Diabetes

The World Market for Butadiene Rubber (BR): A 2009 Global Trade Perspective

The 2009 Import and Export Market for Butadiene Rubber (BR) in Belarus

The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia

The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran

The 2009 Import and Export Market for Butadiene Rubber (BR) in Bulgaria

The 2009 Import and Export Market for Butadiene Rubber (BR) in Estonia

The 2009 Import and Export Market for Butadiene Rubber (BR) in Slovakia

The 2009 Import and Export Market for Butadiene Rubber (BR) in Turkey

The 2009 Import and Export Market for Butadiene Rubber (BR) in Uruguay

The 2009 Import and Export Market for Butadiene Rubber (BR) in France

The 2009 Import and Export Market for Butadiene Rubber (BR) in Germany



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds